SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-020367
Filing Date
2019-07-25
Accepted
2019-07-25 16:05:43
Documents
1
Period of Report
2019-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8627
  Complete submission text file 0000899243-19-020367.txt   10505
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
Interpace Diagnostics Group, Inc. (Issuer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 55 WILLIAM STREET SUITE 240 WELLESLEY MA 02481
Business Address 55 WILLIAM STREET SUITE 240 WELLESLEY MA 02481 781-239-0700
Ampersand 2018 Limited Partnership (Reporting) CIK: 0001734267 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-24249 | Film No.: 19974477